Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I also heard another rumor multiple people were seen running from Amarex Clinical at a full sprint down century blvd heading towards TD Ameritrade,..weird huh?
Ask the janitor that just bought 400,000 shares of CYDY. I heard a rumour the lab technician's brother-in-law's sister bought the other one million.
Are you saying it was Fife that just purchased 400,000 shares of CYDY?
They were buys, over 400,000 shares. Probably the janitor at Amarex, after he overheard the lab discussing CD12 results.
That's 6 different indications for Leronlimab that you just listed. Being very conservative let's say 10 billion market cap for each one, that puts CYDY over 60 billion market cap that's roughly $85 share price, most likely will be closer to $200 at that time. And that's still just the beginning.
It was also very telling when MM answered by saying no we haven't been denied the application is on hold.
Excellent post! This should be pinned up top
The PR will be simple,.. Leronlimab far exceeds both primary and secondary endpoints in CD12 the FDA has approved EUA.. then shorts go bankrupt.
With unblinding as soon as this week the run-up should start tomorrow morning taking CYDY to at least $7 by Friday, but I wouldn't be surprised to see $10 then sell off to $7
The company will make billions when S/C is approved. There, fixed it for you
You said it was going to $4.60 last Friday. Whataboutdat?
I completely agree. And it's very telling and shows the strength of Leronlimab when one of CYDY's biggest critic's on the board also holds a long position in CYDY.
What is it about CYDY that makes you long? In hopesters eyes what makes CYDY a long investment?
You make a good point, the message of the market is very positive that Leronlimab will be approved. CYDY gained over 100% after news the trial reached full enrollment. I would assume those investors, like most, are not concerned with the balance sheet of a pre revenue bio company.
Is it just a coincidence the eIND patients recovered with Leronlimab? That's what I base my investment on not the bashing of the CEO
He added another comment also. Here's the link
It's called leronlimab and it's owned by a crazy little company called CytoDyn. I'm excited for the world (also an owner full disclosure).
— Thomas Landstreet (@TomLandstreet) January 8, 2021
So...you have no idea? Just an unfounded blind accusation?? We should just take your word for it.. gotcha..now it's making sense.
What bait are you referring to? Please elaborate, what is this bait the company threw out?
In the cancer testimonial you are referring to they mentioned the CTC dropping to zero. This could indicate a complete response to Leronlimab treatment. When Keytruda first entered the market it was a third line treatment, they recently got approval for first line. Revenue for Keytruda is nearly 4 billion annually and Keytruda only works on MSI patients, a small subset of cancer patients. Leronlimab is an immunotherapy similar to Keytruda.
I was impressed with the bladder cancer patient. With no other treatment the patients scans are stable, it sounded more like not even detectable which would mean Leronlimab is actually destroying the tumors not just preventing growth. Cancer doesn't stop growing on its own, it was exciting to hear that testimonial.
After the first approval the wheels are turning and the race is on, as the approvals start rolling in it's just a matter of which direction CytoDyn takes, becoming one of the largest Parma companies in the world or recording the largest buyout in pharma history.
Immunomedics just sold for 21 billion dollars after spending years and countless millions, pretty good return on their business. And they only had ONE indication for their drug. With CYDY have 20 plus indications what do you think that puts Cytodyn's buy out, 80 billion? 100 billion? That would be well over $100 per share
And giving more thought to the 87 deaths a portion of those deaths could very well have been after the 28 days which would take the numbers even lower.
How many days Left to unblind??!! Only a few days left, tic tock. And it could come alot sooner than people think.
WRONG! the DSMC recommended the trial continue to meet the primary endpoint AND the FDA just resumed eIND's, they did this after looking at the data, had the FDA seen that Leronlimab was not working they would have rejected the eIND request. Leronlimab will be approved.
I remember hearing the same negative talk about the last CC on Dec 10th. Didn't work out so well for those people. There were those saying the price would drop to $2, didn't happen, it climbed to $7
Looking to hear good news coming from the cancer trial. Typically surveillance takes some time, anywhere from 1 to 3 months between CT or MRI scans so hopefully they have results with the current patients.
Typically in the past CYDY price takes a hit after a CC. I think it's a completely different ball game now. If you look back at the last call Dec 10, that started the steady climb to $7. And being this close to unblinding, not to mention any unsuspecting PR that could drop, day trading will be alot tighter, that combined with a big percentage of shorts that won't chance holding could make for an exciting week.
WRONG The FDA just made it know that Leronlimab is working very well by allowing Leronlimab to be given to all patients. This is a preview that CD12 will be approved
https://www.cytodyn.com/investors/news-events/press-releases/detail/495/fda-accepts-protocol-for-adding-an-open-label-extension-to
The major spike in CYDY will come when they unblind data not the EUA. The EUA will just launch it even higher.
Reminder: if you are short CYDY you're quickly running out of time to cover. You will soon be competing with 25 million other shares.
I completely agree. It will be much more dangerous for the shorts when CytoDyn PR's excellent results from CD12. But will be exciting for CYDY shareholders when they are attempting to buy 25 million shares.
The company chooses how they will PR the news from their trial. Closetinvestor has no say or control when and how the PR comes out.
Secondary endpoint is mortality at 14 days the was up a few days ago. Is it possible they unblind that data next week? Don't blink, that could be the PR that pushes CYDY to $15 then approval takes it to $30 then nasdaq $40 and that's still just the beginning.
Leronlimab was approved to go straight to phase three CD12 covid trial. Bypassing phase 1 and 2, the FDA allowed this because they were impressed with eIND data. And now after the trial is complete AND after having access to the trial data FDA is allowing the trial to continue not only continue but Leronlimab is to be given to all patients. The writing is on the wall, Leronlimab will be approved in a matter of days, the only unknown is which country will approve it first.
But but but...the FDA is waving the checkered flag to Leronlimab. Restarting eIND's and allowing all patients to receive Leronlimab this coming after the FDA had access to CD12 data. The FDA has even given guidance for the eIND because of the many requests from doctors.
https://www.cytodyn.com/investors/news-events/press-releases/detail/495/fda-accepts-protocol-for-adding-an-open-label-extension-to
Larry King needs Leronlimab
https://www.cnn.com/2021/01/02/media/larry-king-covid-19/index.html
Well that looks pretty shady, now we have conflicting reports on the amount of employees and you were all set to prove there's not 50 employees?? Looks like a setup to me.
Speaking of Dr. Jay, he sent out a message to everyone supporting CytoDyn and Leronlimab. Sounds like Leronlimab could cure the pandemic.
To all the folks who hung in there with CytoDyn in 2020 - Thank You! You may yet prove to be heroes of this pandemic 🙏#CYDY#leronlimab
— DrJay (@DrJay62817871) January 2, 2021
Dr Jay is a stand up guy, not only is he saving lives, he saved 50 people's jobs